Expert Opinion on Drug Safety
Volume 21, 2022 - Issue 5
Review
Vortioxetine in major depressive disorder: from mechanisms of action to clinical studies. An updated review
Javier De Diego-Adeliñoa Department of Psychiatry, Hospital de La Santa Creu I Sant Pau, Institut d’Investigació Biomèdica Sant Pau (Iib-sant Pau), Universitat Autònoma de Barcelona (Uab), Centro de Investigación Biomédica En Red de Salud Mental (Cibersam), Spain
https://orcid.org/0000-0001-9708-2441View further author information
https://orcid.org/0000-0001-9708-2441View further author information, , Fernando Morac Department of Psychiatry, Hospital Universitario Infanta Leonor, Madrid, Spainhttps://orcid.org/0000-0003-4698-1679View further author information
https://orcid.org/0000-0003-4698-1679View further author information, , Pedro Iborrae Department of Psychiatry, San Juan University Hospital, Alicante, Spainhttps://orcid.org/0000-0001-9041-0983View further author information
https://orcid.org/0000-0001-9041-0983View further author information, Luis Gutiérrez-Rojasf Department of Psychiatry, San Cecilio University Hospital, Granada, SpainCorrespondence[email protected]
https://orcid.org/0000-0003-0082-2189View further author information
https://orcid.org/0000-0003-0082-2189View further author information & show all